SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Anlon Healthcare Ltd

BSE: 544497 NSE: AHCL ISIN: INE0Y8W01025
  |   Sector:  Healthcare   |   Industry:  Pharmaceuticals & Drugs

Snapshot

Q.1 Which industry/sub-sector does Anlon Healthcare Ltd belong to?
Anlon Healthcare Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.
Q.2 Is Anlon Healthcare Ltd a good quality company?
Anlon Healthcare Ltd is a weak quality company, based on a inconsistent 10 year financial track record.
Q.3 Is Anlon Healthcare Ltd undervalued or overvalued?
Anlon Healthcare Ltd appears Overvalued, as its key valuation ratios are above with their past averages.
Q.4 Is Anlon Healthcare Ltd a good buy now?
Anlon Healthcare Ltd is a good buy now, based on strong price trend analysis suggesting prices may rise. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Anlon Healthcare Ltd?
Anlon Healthcare Ltd revenue growth is 80.7% for FY-2025 , which is above its 5 year CAGR of 0% , indicating faster growth.
Q.2 Gross Profit margin of Anlon Healthcare Ltd?
Anlon Healthcare Ltd Gross profit margin which is the profit after deduction of direct costs, is 23.8% for FY-2025 , which is above its 5 year median of 15.85% , indicating increasing margins.
Q.3 Operating Profit Margin of Anlon Healthcare Ltd?
Anlon Healthcare Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 27.17% for FY-2025 , which is above its 5 year median of 19.31% indicating increasing margins.
Q.4 Net Profit Margin of Anlon Healthcare Ltd?
Anlon Healthcare Ltd Net Profit Margin is 17.06% for FY-2025 , is above with its 5 year median of 11.11%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 23.8 15.85
Operating Profit Margin 27.17 19.31
Net Profit Margin 17.06 11.11
Q.5 Return on Asset of Anlon Healthcare Ltd?
Anlon Healthcare Ltd Return on Asset is 13.27%, which is above its 5 year historical median of 9.6%, indicating improved asset utilization efficiency.
Q.6 Return on Equity (ROE) of Anlon Healthcare Ltd?
Anlon Healthcare Ltd Return on equity is 40.45% for FY-2025 , which is below its historical median of 85.41%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Anlon Healthcare Ltd?
Anlon Healthcare Ltd Return on capital employed is 24.83% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of Anlon Healthcare Ltd?
Anlon Healthcare Ltd Cash conversion cycle is 226 days, above its historical median of 196 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.78 0.91
ROE 40.45 85.41
ROCE 24.83 20.13
Cash Conversion Cycle 226 days 196 days
Q.9 Debt to Equity ratio of Anlon Healthcare Ltd?
Anlon Healthcare Ltd Debt-to-Equity ratio is 0.83 , which is above with the industry average of 0.15 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Anlon Healthcare Ltd?
Anlon Healthcare Ltd Debt to cash flow from operations is -2.95 , which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Anlon Healthcare Ltd?
Promoters hold 52.68% of the Anlon Healthcare Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Anlon Healthcare Ltd vs industry peers?
Anlon Healthcare Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 5.51% , indicating slower growth and losing its market share.
Profit Metrics
Current Level Industry Median
Revenue 120.3 138.8
Gross Profit 28.6 16.2
Operating Profit 33 16
Net Profit 21 5.3
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.78 0.79
ROE 40.45 9.17
ROCE 24.83 11.78
Cash Conversion Cycle (days) 225.79 76

Valuation & price assessment

Q.1 Stock return of Anlon Healthcare Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price - - - -
Q.3 Valuation ratios of Anlon Healthcare Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 37.24 33.30 40.28
Price to Book 3.48 3.36 2.77
Price to Sales 6.35 5.68 2.65
EV to EBITDA 24.36 22.77 15.67

Check more companies

1. Ajanta Pharma
2. JB Chem & Pharma
3. Emcure Pharma
4. Gland Pharma
5. Wockhardt
6. Sai Life Sciences
7. Pfizer
8. Piramal Pharma
9. Astrazeneca Pharma I
10. Onesource Specialty
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×